TP53 and neoplasm: Even so, the ETS-related gene is overexpressed in prostate cells and leads to resistance to cabazitaxel treatment 91 by aborting p53 function, deregulating apoptosis, overexpressing HER2 and inhibiting tumor cell permeability 92.